Breaking News

Novacap Acquires PCI Synthesis

Expands pharma offering in the U.S.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, has signed an agreement to acquire Boston-based PCI Synthesis, a U.S. pharmaceutical contract development and manufacturing organization (CDMO). Located in Boston’s booming biotech and pharmaceutical hub, PCI Synthesis offers its customers a wide range of services, including process research and early stage development as well as commercial production of new chemical entities (NCEs), generic APIs and other...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters